Immunity to oncogenic proteins.
Cheever
M A
MA
Department of Medicine, University of Washington, Seattle 98195, USA.
Disis
M L
ML
Bernhard
H
H
Gralow
J R
JR
Hand
S L
SL
Huseby
E S
ES
Qin
H L
HL
Takahashi
M
M
Chen
W
W
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D016044:Fusion Proteins, bcr-abl / Q000276:immunology; D006801:Humans; D015689:Oncogene Protein p21(ras) / Q000276:immunology; D010446:Peptide Fragments / Q000276:immunology; D011518:Proto-Oncogene Proteins / Q000276:immunology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology
D000951:Antigens, Neoplasm; D016044:Fusion Proteins, bcr-abl; D015689:Oncogene Protein p21(ras); D010446:Peptide Fragments; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; C091577:HER2-neu-derived peptide (654-662)